Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.40 |
| ▸ | JAK2 | O60674 | 2/20 | 0.33 |
| ▸ | BTK | Q06187 | 2/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA3 | P07451 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA6 | P23280 | 1/20 | 0.31 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | F11 | P03951 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28845961 | 0.74 | LPL (0.43) | LPLLIPG | |
| SCHEMBL18173799 | 0.71 | HDAC8 (0.41) | LPLLIPG | |
| SCHEMBL24141578 | 0.71 | LPL (0.38) | LPLLIPGP2RX7CA1CA2 | |
| SCHEMBL19885232 | 0.70 | LPL (0.41) | LPLLIPGP2RX7CA1CA2 | |
| SCHEMBL19887482 | 0.70 | LPL (0.33) | LPLLIPG | |
| SCHEMBL18092375 | 0.68 | LIPG (0.37) | LPLLIPGJAK2BTKP2RX7 | |
| SCHEMBL23089229 | 0.68 | JAK2 (0.41) | LPLLIPGJAK2BTK | |
| SCHEMBL23104647 | 0.67 | CDK8 (0.41) | LPLLIPGP2RX7 | |
| SCHEMBL860007 | 0.67 | BUB1 (0.40) | F11 | |
| SCHEMBL21630705 | 0.66 | LPL (0.35) | LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11721838-B2 | Electrolyte and electrochemical apparatus | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2023-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11721838-B2 | Electrolyte and electrochemical apparatus | HCN2, HCN3, KCNH3 | LPL 4442/4885LIPG 4064/4885JAK2 2252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.